Clinical Trial Detail

NCT ID NCT02273102
Title Phase 1 Study of TCP-ATRA for Adult Patients With AML and MDS (TCP-ATRA)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Miami
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Tranylcypromine + Tretinoin

Age Groups: adult senior

No variant requirements are available.